These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 19190259)
1. Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic status. Babraj JA; Mustard K; Sutherland C; Towler MC; Chen S; Smith K; Green K; Leese G; Hardie DG; Rennie MJ; Cuthbertson DJ Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1042-8. PubMed ID: 19190259 [TBL] [Abstract][Full Text] [Related]
3. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats. Oki K; Arias EB; Kanzaki M; Cartee GD Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344 [TBL] [Abstract][Full Text] [Related]
4. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle. Suwa M; Nakano H; Radak Z; Kumagai S Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304 [TBL] [Abstract][Full Text] [Related]
5. Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes. Gaidhu MP; Perry RL; Noor F; Ceddia RB Mol Endocrinol; 2010 Jul; 24(7):1434-40. PubMed ID: 20501641 [TBL] [Abstract][Full Text] [Related]
6. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside. Bradley EA; Zhang L; Genders AJ; Richards SM; Rattigan S; Keske MA Cardiovasc Diabetol; 2015 Jul; 14():91. PubMed ID: 26194188 [TBL] [Abstract][Full Text] [Related]
8. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion. Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328 [TBL] [Abstract][Full Text] [Related]
9. Differential attenuation of AMPK activation during acute exercise following exercise training or AICAR treatment. McConell GK; Manimmanakorn A; Lee-Young RS; Kemp BE; Linden KC; Wadley GD J Appl Physiol (1985); 2008 Nov; 105(5):1422-7. PubMed ID: 18703760 [TBL] [Abstract][Full Text] [Related]
10. Independent and combined effects of calorie restriction and AICAR on glucose uptake and insulin signaling in skeletal muscles from 24-month-old female and male rats. Wang H; Zheng A; Thorley D; Arias EB; Cartee GD Appl Physiol Nutr Metab; 2024 May; 49(5):614-625. PubMed ID: 38181403 [TBL] [Abstract][Full Text] [Related]
11. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake. Al-Khalili L; Krook A; Zierath JR; Cartee GD Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951 [TBL] [Abstract][Full Text] [Related]
12. Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients. Boon H; Bosselaar M; Praet SF; Blaak EE; Saris WH; Wagenmakers AJ; McGee SL; Tack CJ; Smits P; Hargreaves M; van Loon LJ Diabetologia; 2008 Oct; 51(10):1893-900. PubMed ID: 18709353 [TBL] [Abstract][Full Text] [Related]
13. Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. Bogachus LD; Turcotte LP Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1549-61. PubMed ID: 20844250 [TBL] [Abstract][Full Text] [Related]
14. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction. Raney MA; Yee AJ; Todd MK; Turcotte LP Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141 [TBL] [Abstract][Full Text] [Related]
15. AMPK activation with AICAR provokes an acute fall in plasma [K+]. Zheng D; Perianayagam A; Lee DH; Brannan MD; Yang LE; Tellalian D; Chen P; Lemieux K; Marette A; Youn JH; McDonough AA Am J Physiol Cell Physiol; 2008 Jan; 294(1):C126-35. PubMed ID: 18003746 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways. Jing M; Cheruvu VK; Ismail-Beigi F Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1071-82. PubMed ID: 18701654 [TBL] [Abstract][Full Text] [Related]
17. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Merrill GF; Kurth EJ; Hardie DG; Winder WW Am J Physiol; 1997 Dec; 273(6):E1107-12. PubMed ID: 9435525 [TBL] [Abstract][Full Text] [Related]
18. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Koistinen HA; Galuska D; Chibalin AV; Yang J; Zierath JR; Holman GD; Wallberg-Henriksson H Diabetes; 2003 May; 52(5):1066-72. PubMed ID: 12716734 [TBL] [Abstract][Full Text] [Related]
19. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients. Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433 [TBL] [Abstract][Full Text] [Related]
20. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. Gaidhu MP; Fediuc S; Ceddia RB J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]